UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Volume measurement of bone erosions in magnetic resonance images of patients with rheumatoid arthritis

Magnetic resonance in medicine, 2012-03, Vol.67 (3), p.814-823

2012

Volltextzugriff (PDF)

Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson's disease

Scientific reports, 2017-05, Vol.7 (1), p.1398-9, Article 1398

2017

Volltextzugriff (PDF)

Analysis of the Risk of Infection Stratified By Absolute Neutrophil Counts during Deferiprone-Associated Severe Neutropenia or Agranulocytosis

Blood, 2023, Vol.142 (Supplement 1), p.2501-2501

2023

Volltextzugriff (PDF)

Deferiprone‐induced agranulocytosis: 20 years of clinical observations

American journal of hematology, 2016-10, Vol.91 (10), p.1026-1031

2016

Volltextzugriff (PDF)

Sickle Cell Disease: New Opportunities and Challenges in Africa

TheScientificWorld, 2013-01, Vol.2013 (2013), p.1-16

2013

Volltextzugriff (PDF)

S115: LONG‐TERM EFFICACY AND SAFETY OF DEFERIPRONE FOR PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANEMIAS

HemaSphere, 2022-01, Vol.6, p.8-8

2022

Volltextzugriff (PDF)

Rates of severe neutropenia and infection risk in patients treated with deferiprone: 28 years of data

Blood advances, 2024-04

2024

Volltextzugriff (PDF)

P1511: EFFICACY AND SAFETY OF COMBINATION IRON CHELATION THERAPY WITH DEFERIPRONE AND DEFERASIROX IN PATIENTS WITH Β‐THALASSEMIA MAJOR: A SYSTEMATIC LITERATURE REVIEW

HemaSphere, 2022-06, Vol.6 (Suppl), p.1392-1393

2022

Volltextzugriff (PDF)

PB2231: RATIONALE FOR THE USE OF COMBINATION CHELATION THERAPY IN PATIENTS WITH THALASSEMIA SYNDROMES OR SICKLE CELL ANEMIA: A SYSTEMATIC LITERATURE REVIEW

HemaSphere, 2022-06, Vol.6 (Suppl), p.2101-2102

2022

Volltextzugriff (PDF)

S115: LONG-TERM EFFICACY AND SAFETY OF DEFERIPRONE FOR PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANEMIAS

HemaSphere, 2022-01, Vol.6 (Suppl), p.8-8

2022

Volltextzugriff (PDF)

S120: RANDOMIZED CONTROLLED TRIAL OF THE EFFICACY AND SAFETY OF DEFERIPRONE: SUBGROUP ANALYSIS OF PEDIATRIC PATIENTS IN IRON‐OVERLOADED PATIENTS WITH SICKLE CELL DISEASE AND OTHER ANEMIAS

HemaSphere, 2022-01, Vol.6 (Suppl), p.10-11

2022

Volltextzugriff (PDF)

LONG-TERM SAFETY AND EFFICACY OF DEFERIPRONE FOR THE TREATMENT OF CHRONICALLY TRANSFUSED, IRON-OVERLOADED PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANEMIAS

Hematology, Transfusion and Cell Therapy, 2021-10, Vol.43, p.S23-S24

2021

Volltextzugriff (PDF)

RANDOMIZED CONTROLLED TRIAL OF THE EFFICACY AND SAFETY OF DEFERIPRONE: SUBGROUP ANALYSIS OF PEDIATRIC PATIENTS IN IRON-OVERLOADED PATIENTS WITH SICKLE CELL DISEASE AND OTHER ANEMIAS

Hematology, Transfusion and Cell Therapy, 2022-10, Vol.44, p.S338-S339

2022

Volltextzugriff (PDF)

Randomized, Blinded, Placebo‐ and Positive‐Controlled Crossover Study to Determine the Effect of Deferiprone on the QTc Interval in Healthy Subjects

Clinical pharmacology in drug development, 2018-01, Vol.7 (1), p.22-32

2018

Volltextzugriff (PDF)

Methods of assessing iron overload: Time for reappraisal

European journal of clinical investigation, 2004-04, Vol.34, p.42

2004

Volltextzugriff (PDF)

Iron Chelation with Oral Deferiprone in Patients with Thalassemia

The New England journal of medicine, 1998-12, Vol.339 (23), p.1710-1714

1998

Volltextzugriff (PDF)

Complexities in the Rat Iron Loading Model for Pre-Clinical Testing of Iron Chelators

Blood, 2004-11, Vol.104 (11), p.3699-3699

2004

Volltextzugriff (PDF)

Long-term study of the toxicity of deferiprone in iron-loaded and naive monkeys: impact of divided daily dosing

European journal of clinical investigation, 2004-04, Vol.34, p.42

2004

Volltextzugriff (PDF)

The Olivieri Case

The New England journal of medicine, 2003-02, Vol.348 (9), p.860-863

2003

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(19)
Tagungsberichte
(1)

Sprache

Englisch
(20)

Erscheinungsjahr

n.n

Thema

Science & Technology
(8)
Humans
(7)
Life Sciences & Biomedicine
(6)
Female
(5)
Iron Chelating Agents - Therapeutic Use
(5)
Male
(5)
Middle Aged
(5)
Adult
(4)
Pyridones - Therapeutic Use
(4)
Aged
(3)
Double-Blind Method
(3)
Iron Chelating Agents - Adverse Effects
(3)
Iron Overload - Drug Therapy
(3)
Medicin Och Hälsovetenskap
(3)
Adolescent
(2)
Aged, 80 And Over
(2)
Chelation
(2)
Child
(2)
Child, Preschool
(2)
Clinical And Epidemiological Studies
(2)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Volume measurement of bone erosions in magnetic resonance images of patients with rheumatoid arthritis

Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson's disease

Analysis of the Risk of Infection Stratified By Absolute Neutrophil Counts during Deferiprone-Associated Severe Neutropenia or Agranulocytosis

Deferiprone‐induced agranulocytosis: 20 years of clinical observations

Sickle Cell Disease: New Opportunities and Challenges in Africa

Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study

S115: LONG‐TERM EFFICACY AND SAFETY OF DEFERIPRONE FOR PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANEMIAS

Rates of severe neutropenia and infection risk in patients treated with deferiprone: 28 years of data

P1511: EFFICACY AND SAFETY OF COMBINATION IRON CHELATION THERAPY WITH DEFERIPRONE AND DEFERASIROX IN PATIENTS WITH Β‐THALASSEMIA MAJOR: A SYSTEMATIC LITERATURE REVIEW

PB2231: RATIONALE FOR THE USE OF COMBINATION CHELATION THERAPY IN PATIENTS WITH THALASSEMIA SYNDROMES OR SICKLE CELL ANEMIA: A SYSTEMATIC LITERATURE REVIEW

S115: LONG-TERM EFFICACY AND SAFETY OF DEFERIPRONE FOR PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANEMIAS

S120: RANDOMIZED CONTROLLED TRIAL OF THE EFFICACY AND SAFETY OF DEFERIPRONE: SUBGROUP ANALYSIS OF PEDIATRIC PATIENTS IN IRON‐OVERLOADED PATIENTS WITH SICKLE CELL DISEASE AND OTHER ANEMIAS

LONG-TERM SAFETY AND EFFICACY OF DEFERIPRONE FOR THE TREATMENT OF CHRONICALLY TRANSFUSED, IRON-OVERLOADED PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANEMIAS

RANDOMIZED CONTROLLED TRIAL OF THE EFFICACY AND SAFETY OF DEFERIPRONE: SUBGROUP ANALYSIS OF PEDIATRIC PATIENTS IN IRON-OVERLOADED PATIENTS WITH SICKLE CELL DISEASE AND OTHER ANEMIAS

Randomized, Blinded, Placebo‐ and Positive‐Controlled Crossover Study to Determine the Effect of Deferiprone on the QTc Interval in Healthy Subjects

Methods of assessing iron overload: Time for reappraisal

Iron Chelation with Oral Deferiprone in Patients with Thalassemia

Complexities in the Rat Iron Loading Model for Pre-Clinical Testing of Iron Chelators

Long-term study of the toxicity of deferiprone in iron-loaded and naive monkeys: impact of divided daily dosing

The Olivieri Case

Suchergebnisse filtern